HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.

AbstractBACKGROUND:
Sarcoidosis is a multisystemic granulomatous disease with an unpredictable clinical course characterized by accumulation of activated proliferating T lymphocytes and mononuclear phagocytes in affected organs.
AIMS AND METHODS:
The aims of this study were to describe the clinical, radiological and immunological features of a population of sarcoidosis patients followed at the Sarcoidosis Regional Centre in Siena and to analyse chitotriosidase and sIL-2R concentrations in serum of these patients in order to understand their potential as disease markers.
RESULTS:
Chitotriosidase and sIL-2R concentrations in serum of sarcoidosis patients were found to be significantly higher than in healthy controls (p<0.01) and a positive correlation between the two markers was documented for the first time. Moreover, chitotriosidase and sIL-2R were expressed differently in different radiographic stages of the disease.
CONCLUSION:
Chitotriosidase and sIL-2R are two markers of sarcoidosis of different origin, the values of which show a correlation in these patients; they are easily detectable in serum and could be useful clinical markers of progression.
AuthorsElena Bargagli, Nicola Bianchi, Maria Margollicci, Carmela Olivieri, Alice Luddi, Giuseppe Coviello, Salvatore Grosso, Paola Rottoli
JournalScandinavian journal of clinical and laboratory investigation (Scand J Clin Lab Invest) Vol. 68 Issue 6 Pg. 479-83 ( 2008) ISSN: 1502-7686 [Electronic] England
PMID18609101 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers
  • Receptors, Interleukin-2
  • Hexosaminidases
  • chitotriosidase
Topics
  • Biomarkers (blood)
  • Female
  • Health
  • Hexosaminidases (metabolism)
  • Humans
  • Male
  • Middle Aged
  • Receptors, Interleukin-2 (blood)
  • Sarcoidosis (blood, enzymology, pathology)
  • Smoking
  • Solubility

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: